Evidence map›Paper›PMID 35450296›Full record

ArticleBiochemistry research international2022

Annotating Spike Protein Polymorphic Amino Acids of Variants of SARS-CoV-2, Including Omicron.

Gusti Ngurah Mahardika, Nyoman B Mahendra, Bayu K Mahardika, Ida B K Suardana, Made Pharmawati

Abstract read
In one paragraph

Article in Biochemistry research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gusti Ngurah MahardikaThe Animal Biomedical and Molecular Biology Laboratory, Udayana University, Jl. Sesetan-Markisa 6A, Denpasar 80223, Bali, Indonesia.ORCID https://orcid.org/0000-0001-5525-0793
Nyoman B MahendraThe Department of Obstetrics and Genecology, The Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia.ORCID https://orcid.org/0000-0001-9336-8186
Bayu K MahardikaThe Animal Biomedical and Molecular Biology Laboratory, Udayana University, Jl. Sesetan-Markisa 6A, Denpasar 80223, Bali, Indonesia.ORCID https://orcid.org/0000-0002-8551-2675
Ida B K SuardanaVirology Laboratory, The Faculty of Veterinary Medicine, Udayana University, Denpasar, Bali, Indonesia.ORCID https://orcid.org/0000-0002-7385-5240
Made PharmawatiThe Biology Study Program, The Faculty of Mathematic and Natural Science, Udayana University, Kampus Bukit Jimbaran, Badung, Bali, Indonesia.ORCID https://orcid.org/0000-0002-3064-4582

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prolonged global spread and community transmission of severe acute respiratory syndrome virus 2 (SARS-CoV-2) has led to the emergence of variants and brought questions regarding disease severity and vaccine effectiveness. We conducted simple bioinformatics on the spike gene of a representative of each variant. The data show that a number of polymorphic amino acids are located mostly on the amino-terminal side of the S1/S2 cleavage site. The Omicron variant diverges from the others, with the highest number of amino acid substitutions, including the receptor-binding site (RBS), epitopes, S1/S2 cleavage site, fusion peptide, and heptad repeat 1. The current sharp global increase in the frequency of the Omicron genome constitutes evidence of its high community transmissibility. In conclusion, the proposed guideline could give an immediate insight of the probable biological nature of any variant of SARS-Cov-2. As the Omicron diverged the farthest from the original pandemic strain, Wuhan-Hu-1, we expect different epidemiological and clinical patterns of Omicron cases. On vaccine efficacy, slight changes in some epitopes while others are conserved should not lead to a significant reduction in the effectiveness of an approved vaccine.

Identifiers

PMID35450296
PMCPMC9017565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.